Characteristic | No.(%) of patients |
---|---|
Gender | Total: 513 |
Male | 266(52.0 %) |
Female | 247(48.0 %) |
Primary/recurrence | Total: 513 |
Primary | 342(66.6 %) |
Recurrence | 171(33.3 %) |
Co-morbidities | Total: 173 |
High blood pressure | 45(26.6 %) |
Myocardial infarction | 34(20.0 %) |
COPD | 11(6.4 %) |
Bronchitis | 13(7.5 %) |
Diabetes | 31(17.9 %) |
Hypothyroidism | 10(5.8 %) |
Hyperthyroidism | 3(1.7 %) |
Agitation | 5(2.9 %) |
Delirium | 3(1.7 %) |
Metabolism | 6(3.5 %) |
Acid reflux | 6(3.5 %) |
Renal failure | 6(3.5 %) |
Pathological grading | Total: 513 |
I | 148(28.8 %) |
II | 262(51.0 %) |
III | 113(22.0 %) |
Unidentified | 47(9.0 %) |
Clinical grading | Total: 513 |
T1 | 148(%) |
T2 | 262(%) |
T3 | 47(%) |
T4 | 56(%) |
Region | Total: 513 |
Upper lip | 5(1.0 %) |
Lower lip | 15(2.9 %) |
Maxillofacial | 17(3.3 %) |
Floor of mouth | 33(6.4 %) |
Tongue | 122(23.4 %) |
Oral-pharyngeal | 12(2.5 %) |
Hypopharynx | 12(2.5 %) |
Neck | 49(9.6 %) |
Maxilla | 52(10.1 %) |
Mandible | 123(24.0 %) |
Buccal mucosa | 65(12.7 %) |
Parotid gland | 6(1.2 %) |
Surgical classification | Total: 513 |
IO | 149(30.9 %) |
JO | 261(50.1 %) |
SMO | 103(20.0 %) |
Postoperative complications | Total: 292 |
Wound infection | 35(12.0 %) |
Free flap infection | 23(4.5 %) |
Edema | 46(15.8 %) |
Wound dehiscence | 40(13.7 %) |
Hematoma with re-exploration | 15(5.5 %) |
Hematoma without re-exploration | 10(3.4 %) |
Partial flap necrosis | 17(5.8 %) |
Total flap necrosis | 4(1.4 %) |
Pneumonia | 19(4.8 %) |
Pulmonary embolus | 1(0.3 %) |
Salivary fistula | 16(5.5 %) |
Abdominal discomfort | 5(1.7 %) |
Haematemesis | 4(1.4 %) |
Central nerve system co-morbidity | 8(2.7 %) |
Deep venous thrombosis (DVT) | 7(2.4 %) |
Angina | 6(2.1 %) |
Delirium | 8(2.7 %) |